ChatCPT has potential to diagnose Alzheimer’s disease … C. diff antibiotic lowered recurrence … Combo therapy reduces blood pressure in ibrutinib patients … FDA eyes improving accuracy of pulse...
Clinical briefs for Thursday, Oct. 5
By
Kristen Fischer
Oct 05, 2023
Graphene oxide can make amyloid peptides in Alzheimer’s less toxic … SGLT2 inhibitors among diabetes meds that may prevent Parkinsons, study says … Bioprinted skin can speed up wound healing …...
Pressure injuries found in 11% of SNF stroke rehab patients
By
Alicia Lasek
Oct 07, 2022
Eleven percent of older patients have pressure injuries when admitted to SNFs for post-acute stroke rehabilitation, a new study has found.
Clinical briefs for Monday, Feb. 27
By
Alicia Lasek
Feb 26, 2023
NIH: Spinal cord stimulation may restore arm and hand mobility after stroke … Screening rates for certain cancers must pick up after pandemic slowdown, analysts say … Antibiotics for COVID more commonly...
Clinical briefs for Monday, Dec. 12
By
Alicia Lasek
Dec 12, 2022
With repeal of Pentagon’s vaccine mandate, will CMS mandate remain a sure thing? … Hospital beds are 80% full nationwide, only 6% due to COVID … AHCA urges nursing homes to get involved in ’game-changing’...
Clinical briefs for Wednesday, January 25
By
Alicia Lasek
Jan 25, 2023
Toolkit provides clinical resources for COVID vaccination and therapeutics in PALTC organizations … Assistive program helps primary care docs with diagnoses of skin conditions … HHS report: Medicare...
Ask the resident care expert … about precaution types
By
Sherrie Dornberger
Jan 25, 2023
Q: We are confused about the difference between contact precautions and enhanced barrier precautions. Can you help?
Ask the wound care expert… about the costs of wound care
By
Fatima Naqvi, MD
Dec 07, 2023
A 2014 analysis of Medicare spending found between $28.1 billion and $96.8 billion per year was spent on wound care in the US.
Report: Doctors doling out antifungal creams at high rates, causing drug resistance
By
Kristen Fischer
Jan 16, 2024
Doctors in the United States are prescribing antifungal creams at rates so high they could be contributing to the rise of drug-resistant infections, new research shows.